Unmetabolized folic acid in serum: Acute studies in subjects consuming fortified food and supplements

American Journal of Clinical Nutrition

Volumn 65, Issue 6, 1997, Pages 1790-1795

  Kelly, Patrick ^b   McPartlin, Joseph ^a   Goggins, Michael ^b   Weir, Donald G ^b   Scott, John M ^b  

^a ST JAMES S HOSPITAL   (Ireland)

^b NONE

Author keywords

Folic acid; Food fortification; Humans; Metabolism threshold; Neural tube defects; Safety; Serum; Supplements

Indexed keywords

COBALAMIN; FOLIC ACID;

ADULT; AGED; ARTICLE; DIET SUPPLEMENTATION; FEMALE; FOOD AND DRUG ADMINISTRATION; FOOD INTAKE; HUMAN; HUMAN EXPERIMENT; MALE; NEUROLOGIC DISEASE; PERNICIOUS ANEMIA;

EID: 0030962568     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/65.6.1790     Document Type: Article

References (27)

1. Scott JM, Weir DG, Kirke PN. Folate and neural tube defects. In: Bailey L, ed. Folate in health and disease. New York: Marcel Dekker, 1995:329-60.
2. Lucock M, Wild J, Smithells R, Hartley R. Biotransformation of pteroylmonoglutamic acid during absorption: implications of Michaelis-Menton kinetics. Eur J Clin Nutr 1989;43:631-5.
3. Kelly P, McPartlin J, Scott J. A combined high-performance liquid chromatographic - microbiological assay for serum folic acid. Anal Biochem 1996;238:179-83.
4. Gaull GE, Testa CA, Thomas PR, Weinreich DA. Fortification of the food supply with folic acid to prevent neural tube defects is not yet warranted. J Nutr 1996;126(suppl):773S-80S.
5. Crane NT, Wilson DB, Cook A, Lewis CJ, Yetley EA, Rader JI. Evaluating food fortification options: general principles revisited with folic acid. Am J Public Health 1995;85:660-6.
6. Food and Drug Administration. Food labeling: health claims and food label statements; folate and neural tube defects. Fed Regist 1996;61(44):8752-807.
7. Oakley GP, Adams MJ, Dickinson CM. More folic acid for everyone, now. J Nutr 1996;126(suppl):751S-5S.
8. O'Broin S, Kellegher B. Microbiological assay on microtitre plates of folate in serum and red cells. J Clin Pathol 1992;45:344-7.
9. Scott J, Weir DG, Kirke PN. Prevention of neural tube defects with folic acid a success but. . . . Q J Med 1994;87:705-7.
10. Butterworth CE Jr, Tamura T. Folic acid safety and toxicity: a brief review. Am J Clin Nutr 1989;50:353-9.
11. 12 deficiency? Q J Med 1995;88:357-64.
12. Backman N, Holm AK, Hanstrom L, Blomquist HK, Heijbel J, Safstrom G. Folate treatment of diphenylhydantoin-induced gingival hyperplasia. Scand J Dent Res 1989;97:222-32.
13. Brown RS, Di-Stanislao PT, Beaver WT, Bottomly WT. The administration of folic acid to institutionalised epileptic adults with phenytoin-induced gingival hyperplasia. A double-blind, randomised, placebo-controlled, parallel study. Oral Surg Oral Med Oral Pathol 1991;71:565-8.
14. Morgan S, Baggott JE. Folate antagonists in nonneoplastic disease: proposed mechanisms of efficacy and toxicity. In: Bailey L, ed. Folate in health and disease. New York: Marcel Dekker, 1995:405-33.
15. Albrecht AM, Biedler JL. Acquired resistance of tumor cells to folate antagonists. In: Sirotnik FM, Burchall JJ, Ensminger WB, Montgomery JA, eds. Folate antagonists as therapeutic agents. 1. Biochemistry, molecular actions and synthetic design. New York: Academic Press, 1984: 317-47.
16. Mason JB. Intestinal transport of monoglutamyl folates in mammalian systems. In: Picciano MF, Stokstad ELR, Gregory JF, eds. Contemporary issues in clinical nutrition. 13. Folic acid metabolism in health and disease. New York: Wiley-Liss, 1990:47-63.
17. Cichowicz DJ, Shane B. Mammalian folylpoly-γ-glutamate synthetase. 2. Substrate specificity and kinetic properties. Biochemistry 1987;26:513-21.
18. 12 deficiency. Blood 1973;41:465-9.
19. Metz J, Kelly A, Swett VC, Waxman S, Herbert V. Deranged DNA synthesis by bone marrow from vitamin B-12-deficient humans. Br J Haematol 1968;14:575-92.
20. Ganeshaguru K, Hoffbrand AV. The effect of deoxyuridine, vitamin B-12, folate and alcohol on the uptake of thymidine ond on the deoxynucleoside triphosphate concentrations in normal and megaloblastic cells. Br J Haematol 1978;40:29-41.
21. 12 and folate deficiency. Blood 1978;51:119-28.
22. Scott JM, Dinn JJ, Wilson P, Weir DG. Pathogenesis of subacute combined degeneration: a result of methyl group deficiency. Lancet 1981;2:334-7.
23. Chanarin I. The megaloblastic anaemias. Oxford, United Kingdom: Blackwell Scientific Publications, 1979.
24. Keagy PM, Shane B, Oace SM. Folate bioavailability in humans: effects of wheat bran and beans. Am J Clin Nutr 1988;47:80-8.
25. Bailey LB, Barton LE, Hillier SE, Cerda JJ. Bioavailability of mono and polyglutamylfolate in human subjects. Nutr Rep Int 1988;38:509-18.
26. Colman N, Green R, Metz J. Prevention of folate deficiency by food fortification. II. Absorption of folic acid from staple foods. Am J Clin Nutr 1975;28:459-64.
27. Cuskelly GJ, McNulty H, Scott JM. Effect of increasing dietary folate on red cell folate - complications for prevention of neural tube defects. Lancet 1996;347:657-9.